Your browser doesn't support javascript.
loading
Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer.
Petrone, Giulia; Gaulin, Charles; Derkach, Andriy; Kishtagari, Ashwin; Robson, Mark E; Parameswaran, Rekha; Stein, Eytan M.
Affiliation
  • Petrone G; Department of Medicine, Mount Sinai Morningside and Mount Sinai West, New York, NY.
  • Gaulin C; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix.
  • Derkach A; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Kishtagari A; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Robson ME; Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Parameswaran R; Division of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Stein EM; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. steine@mskcc.org.
Haematologica ; 108(1): 161-170, 2023 01 01.
Article in En | MEDLINE | ID: mdl-35770528
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Breast Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Haematologica Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Breast Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Haematologica Year: 2023 Type: Article